These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 18443227)

  • 41. Engineering of Isogenic Cells Deficient for MR1 with a CRISPR/Cas9 Lentiviral System: Tools To Study Microbial Antigen Processing and Presentation to Human MR1-Restricted T Cells.
    Laugel B; Lloyd A; Meermeier EW; Crowther MD; Connor TR; Dolton G; Miles JJ; Burrows SR; Gold MC; Lewinsohn DM; Sewell AK
    J Immunol; 2016 Aug; 197(3):971-82. PubMed ID: 27307560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Brain astrocytes and microglia express functional MR1 molecules that present microbial antigens to mucosal-associated invariant T (MAIT) cells.
    Priya R; Brutkiewicz RR
    J Neuroimmunol; 2020 Dec; 349():577428. PubMed ID: 33096293
    [TBL] [Abstract][Full Text] [Related]  

  • 43. What Makes MAITs Wait?
    Exley MA
    Immunity; 2016 Jan; 44(1):7-9. PubMed ID: 26789915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of mucosal-associated invariant T cells in infectious diseases.
    Wong EB; Ndung'u T; Kasprowicz VO
    Immunology; 2017 Jan; 150(1):45-54. PubMed ID: 27633333
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biased MAIT TCR Usage Poised for Limited Antigen Diversity?
    Souter MNT; Eckle SBG
    Front Immunol; 2020; 11():1845. PubMed ID: 33013835
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection.
    Chua WJ; Truscott SM; Eickhoff CS; Blazevic A; Hoft DF; Hansen TH
    Infect Immun; 2012 Sep; 80(9):3256-67. PubMed ID: 22778103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activating Mucosal-Associated Invariant T Cells Induces a Broad Antitumor Response.
    Ruf B; Catania VV; Wabitsch S; Ma C; Diggs LP; Zhang Q; Heinrich B; Subramanyam V; Cui LL; Pouzolles M; Evans CN; Chari R; Sakai S; Oh S; Barry CE; Barber DL; Greten TF
    Cancer Immunol Res; 2021 Sep; 9(9):1024-1034. PubMed ID: 34193462
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules?
    Mondot S; Boudinot P; Lantz O
    Immunogenetics; 2016 Aug; 68(8):537-48. PubMed ID: 27393664
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The intracellular pathway for the presentation of vitamin B-related antigens by the antigen-presenting molecule MR1.
    McWilliam HE; Eckle SB; Theodossis A; Liu L; Chen Z; Wubben JM; Fairlie DP; Strugnell RA; Mintern JD; McCluskey J; Rossjohn J; Villadangos JA
    Nat Immunol; 2016 May; 17(5):531-7. PubMed ID: 27043408
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diverse MR1-restricted T cells in mice and humans.
    Koay HF; Gherardin NA; Xu C; Seneviratna R; Zhao Z; Chen Z; Fairlie DP; McCluskey J; Pellicci DG; Uldrich AP; Godfrey DI
    Nat Commun; 2019 May; 10(1):2243. PubMed ID: 31113973
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How MR1 Presents a Pathogen Metabolic Signature to Mucosal-Associated Invariant T (MAIT) Cells.
    McWilliam HEG; Villadangos JA
    Trends Immunol; 2017 Sep; 38(9):679-689. PubMed ID: 28688841
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MR1 antigen presentation to MAIT cells and other MR1-restricted T cells.
    McWilliam HEG; Villadangos JA
    Nat Rev Immunol; 2024 Mar; 24(3):178-192. PubMed ID: 37773272
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells.
    Keller AN; Eckle SB; Xu W; Liu L; Hughes VA; Mak JY; Meehan BS; Pediongco T; Birkinshaw RW; Chen Z; Wang H; D'Souza C; Kjer-Nielsen L; Gherardin NA; Godfrey DI; Kostenko L; Corbett AJ; Purcell AW; Fairlie DP; McCluskey J; Rossjohn J
    Nat Immunol; 2017 Apr; 18(4):402-411. PubMed ID: 28166217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MAIT Cells in Health and Disease.
    Magalhaes I; Solders M; Kaipe H
    Methods Mol Biol; 2020; 2098():3-21. PubMed ID: 31792812
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human TRAV1-2-negative MR1-restricted T cells detect S. pyogenes and alternatives to MAIT riboflavin-based antigens.
    Meermeier EW; Laugel BF; Sewell AK; Corbett AJ; Rossjohn J; McCluskey J; Harriff MJ; Franks T; Gold MC; Lewinsohn DM
    Nat Commun; 2016 Aug; 7():12506. PubMed ID: 27527800
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Control of the temporal development of Alzheimer's disease pathology by the MR1/MAIT cell axis.
    Wyatt-Johnson SK; Kersey HN; Codocedo JF; Newell KL; Landreth GE; Lamb BT; Oblak AL; Brutkiewicz RR
    J Neuroinflammation; 2023 Mar; 20(1):78. PubMed ID: 36944969
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Translatome analyses by bio-orthogonal non-canonical amino acid labeling reveal that MR1-activated MAIT cells induce an M1 phenotype and antiviral programming in antigen-presenting monocytes.
    Jakob J; Kröger A; Klawonn F; Bruder D; Jänsch L
    Front Immunol; 2023; 14():1091837. PubMed ID: 36875139
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD8 coreceptor engagement of MR1 enhances antigen responsiveness by human MAIT and other MR1-reactive T cells.
    Souter MNT; Awad W; Li S; Pediongco TJ; Meehan BS; Meehan LJ; Tian Z; Zhao Z; Wang H; Nelson A; Le Nours J; Khandokar Y; Praveena T; Wubben J; Lin J; Sullivan LC; Lovrecz GO; Mak JYW; Liu L; Kostenko L; Kedzierska K; Corbett AJ; Fairlie DP; Brooks AG; Gherardin NA; Uldrich AP; Chen Z; Rossjohn J; Godfrey DI; McCluskey J; Pellicci DG; Eckle SBG
    J Exp Med; 2022 Sep; 219(9):. PubMed ID: 36018322
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alternative splicing of MR1 regulates antigen presentation to MAIT cells.
    Narayanan GA; Nellore A; Tran J; Worley AH; Meermeier EW; Karamooz E; Huber ME; Kurapova R; Tafesse FG; Harriff MJ; Lewinsohn DM
    Sci Rep; 2020 Sep; 10(1):15429. PubMed ID: 32963314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atypical TRAV1-2
    Awad W; Meermeier EW; Sandoval-Romero ML; Le Nours J; Worley AH; Null MD; Liu L; McCluskey J; Fairlie DP; Lewinsohn DM; Rossjohn J
    J Biol Chem; 2020 Oct; 295(42):14445-14457. PubMed ID: 32817339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.